Track JNJ and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Main
Market Cap$649.68B
Enterprise Value$677.95B
Revenue (TTM)$97.93B
Net Income (TTM)$21.04B
Free Cash Flow (TTM)$18.71B
Financial Health
Cash$20.76B
Net Debt$28.28B
Debt Ratio0.24
Debt to Equity0.58
Interest Coverage115.71
Valuation (TTM)
Price to Sales6.63
Price to Earnings30.88
EV to EBITDA21.91
Price to Book7.65
Price to Free Cash Flow34.73
Margins (TTM)
Gross Profit Margin75.17%
EBITDA Margin31.60%
Operating Income Margin26.61%
Net Income Margin21.48%
Free Cash Flow Margin19.10%
Returns (5Y Avg)
Return on Invested Capital17.31%
Return on Assets10.53%
Return on Equity31.04%
Return on Total Capital17.31%
Return on Capital Employed16.80%
Dividend Summary
Dividend Yield2.01%
Annual Dividend$5.36
Payout Ratio60.03%
Ex Dividend Date2026-08-25
5-Year Dividend CAGR5.24%
CAGR (5Y)
Revenue2.67%
Diluted EPS14.80%
Total Debt6.33%
Capital Expenditures7.62%
Free Cash Flow-0.49%
CAGR (3Y)
Revenue5.60%
Diluted EPS17.73%
Total Debt6.53%
Capital Expenditures6.42%
Free Cash Flow4.65%
CAGR (1Y)
Revenue6.05%
Diluted EPS89.63%
Total Debt30.84%
Capital Expenditures9.22%
Free Cash Flow-0.73%
$266.39+$0.62|+0.23%
Last updated: Aug 28, 11:01 AM ET
52W High$276.47
52W Low$173.33
50D SMA$257.47
200D SMA$233.49
Volume1.79M
Johnson & Johnson
One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933
IPO
1944
Employees
138,200
Industry
Drug Manufacturers - General
Sector
Healthcare
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q1 20268-6
2
Q4 202550
5
2-quarter cumulative
13 sells7 buys
Analyst Ratings
17 analysts covering
Hold76%recommend hold
Buy
4
Hold
13
Sell
0